BG
ABMD
Bellevue Group’s Abiomed Inc ABMD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-166,355
| Closed | -$40.9M | – | 183 |
|
2022
Q3 | $40.9M | Sell |
166,355
-3,154
| -2% | -$775K | 0.59% | 51 |
|
2022
Q2 | $42M | Buy |
169,509
+19,331
| +13% | +$4.78M | 0.59% | 53 |
|
2022
Q1 | $49.7M | Hold |
150,178
| – | – | 0.58% | 58 |
|
2021
Q4 | $53.9M | Sell |
150,178
-1,000
| -0.7% | -$359K | 0.56% | 62 |
|
2021
Q3 | $49.2M | Hold |
151,178
| – | – | 0.5% | 64 |
|
2021
Q2 | $47.2M | Buy |
151,178
+8,494
| +6% | +$2.65M | 0.46% | 68 |
|
2021
Q1 | $45.5M | Buy |
142,684
+35,127
| +33% | +$11.2M | 0.48% | 67 |
|
2020
Q4 | $34.9M | Buy |
107,557
+6,159
| +6% | +$2M | 0.4% | 72 |
|
2020
Q3 | $28.1M | Buy |
101,398
+4,699
| +5% | +$1.3M | 0.39% | 71 |
|
2020
Q2 | $23.4M | Sell |
96,699
-11,373
| -11% | -$2.75M | 0.33% | 72 |
|
2020
Q1 | $15.7M | Buy |
108,072
+20,233
| +23% | +$2.94M | 0.3% | 67 |
|
2019
Q4 | $15M | Sell |
87,839
-45,192
| -34% | -$7.71M | 0.24% | 74 |
|
2019
Q3 | $23.7M | Sell |
133,031
-1,651
| -1% | -$294K | 0.44% | 52 |
|
2019
Q2 | $35.1M | Buy |
134,682
+75,293
| +127% | +$19.6M | 0.6% | 44 |
|
2019
Q1 | $17M | Buy |
59,389
+20,567
| +53% | +$5.87M | 0.93% | 34 |
|
2018
Q4 | $12.6M | Buy |
38,822
+5,687
| +17% | +$1.85M | 0.83% | 36 |
|
2018
Q3 | $14.9M | Buy |
33,135
+6,054
| +22% | +$2.72M | 0.95% | 36 |
|
2018
Q2 | $11.1M | Sell |
27,081
-169
| -0.6% | -$69.1K | 0.94% | 40 |
|
2018
Q1 | $7.93M | Buy |
27,250
+250
| +0.9% | +$72.7K | 0.79% | 49 |
|
2017
Q4 | $5.06M | Sell |
27,000
-58,110
| -68% | -$10.9M | 0.53% | 48 |
|
2017
Q3 | $14.4M | Buy |
85,110
+1,140
| +1% | +$192K | 1.5% | 19 |
|
2017
Q2 | $12M | Buy |
83,970
+20,300
| +32% | +$2.91M | 1.42% | 23 |
|
2017
Q1 | $7.97M | Buy |
63,670
+18,620
| +41% | +$2.33M | 1.06% | 37 |
|
2016
Q4 | $5.08M | Sell |
45,050
-10,400
| -19% | -$1.17M | 1.04% | 31 |
|
2016
Q3 | $7.13M | Sell |
55,450
-1,750
| -3% | -$225K | 1.29% | 28 |
|
2016
Q2 | $6.25M | Buy |
+57,200
| New | +$6.25M | 1.18% | 28 |
|